We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria. At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too. Our mission is to end bacterial disease.
Founded 202146+ employeesPrivate
$32.2M raisedSeries A· last: series a (Oct 2025)· 7 rounds
Backed by(19 investors)
Capagro · LeadCapHorn Invest · LeadDemeter · LeadEntrepreneurs First · LeadHoxton Ventures · LeadBpifrance · LeadAGORANOV · LeadSPACE-F · Lead+11 more
